Common Stock SEC Reporting - Current
Verified Company Profile 6/24/2016
Contact Info
  • 50 N. Laura Street
  • Suite 2500
  • Jacksonville, FL 32202

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2016 10-Q
CIK 0001094038
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 1992
Employees 4 a/o Apr 01, 2016
Company Officers/Contacts
Glynn Wilson CEO
John Bonfiglio President, COO
Michael Joseph Loiacono CFO, Chief Accounting Officer, Secretary, Treasurer
Company Directors
Glynn Wilson Chairman
John Bonfiglio
Sherry Grisewood
David Laskow-Pooley
Mark Reddish
Frederick G. Wasserman
Company Notes
  • Formerly=GeneMax Corp. until 6-07
  • until 7-02
  • Formerly=EDUVERSE Accelerated Learning Systems, Inc. until 6-99
  • Formerly=Perfect Future, Ltd. until 6-98
Service Providers
Accounting/Auditing Firm
Marcum LLP
750 Third Ave
11th Floor
New York, NY, 10017
United States

Legal Counsel
Sanders Ortoli Vaughn-Flam Rosenstadt LLP
501 Madison Avenue
14th Floor
New York, NY, 10022
United States

Investor Relations Firm
PCG Advisory Group
535 Fifth Avenue
24th Floor
New York, NY, 10017
United States

TPIV Security Details
Share Structure
Market Value1 $38,109,822 a/o Oct 21, 2016
Authorized Shares 41,666,667 a/o Sep 16, 2016
Outstanding Shares 8,375,785 a/o Sep 16, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 6,759,749 a/o Sep 16, 2016
Par Value Not Available
Transfer Agent(s)
Island Stock Transfer
Shareholders of Record 465 a/o Sep 16, 2016
Short Selling Data
Short Interest 22,128 (-0.38%)
Aug 31, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security